$104.81
0.33% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Stock price

$104.81
-4.76 4.34% 1M
-21.02 16.71% 6M
-16.89 13.88% YTD
-17.86 14.56% 1Y
-37.55 26.37% 3Y
-30.76 22.69% 5Y
+6.91 7.05% 10Y
NYSE, Closing price Fri, Sep 06 2024
+0.34 0.33%
ISIN
US98956P1021
Symbol
ZBH
Sector

Key metrics

Market capitalization $21.34b
Enterprise Value $26.77b
P/E (TTM) P/E ratio 21.85
EV/FCF (TTM) EV/FCF 27.37
EV/Sales (TTM) EV/Sales 3.56
P/S ratio (TTM) P/S ratio 2.84
P/B ratio (TTM) P/B ratio 1.69
Dividend yield 0.92%
Last dividend (FY23) $0.96
Revenue growth (TTM) Revenue growth 4.58%
Revenue (TTM) Revenue $7.52b
EBIT (operating result TTM) EBIT $1.36b
Free Cash Flow (TTM) Free Cash Flow $977.90m
Cash position $420.10m
EPS (TTM) EPS $4.80
P/E forward 22.28
P/S forward 2.77
EV/Sales forward 3.47
Short interest 3.23%
Show more

Is Zimmer Biomet Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Zimmer Biomet Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

10x Buy
33%
18x Hold
60%
2x Sell
7%

Analyst Opinions

30 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

Buy
33%
Hold
60%
Sell
7%

Financial data from Zimmer Biomet Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
7,525 7,525
5% 5%
100%
- Direct Costs 2,873 2,873
8% 8%
38%
4,652 4,652
2% 2%
62%
- Selling and Administrative Expenses 1,885 1,885
0% 0%
25%
- Research and Development Expense 448 448
2% 2%
6%
2,319 2,319
5% 5%
31%
- Depreciation and Amortization 964 964
4% 4%
13%
EBIT (Operating Income) EBIT 1,355 1,355
5% 5%
18%
Net Profit 997 997
97% 97%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Zimmer Biomet Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zimmer Biomet Holdings, Inc. Stock News

Negative
Investopedia
2 days ago
Shares of Zimmer Biomet Holdings (ZBH) dropped nearly 9% after the manufacturer of artificial joint replacements and other orthopedic products warned the implementation of a new enterprise resources planning (ERP) system would hit sales and profits in 2024.
Negative
Investors Business Daily
2 days ago
Zimmer Biomet stock tumbled Thursday after the medtech company said implementing a new enterprise system would slug 2024 sales by 1%.
Neutral
PRNewsWire
3 days ago
WARSAW, Ind. , Sept. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that David DeMartino will join the Company as Senior Vice President, Investor Relations, effective September 9, 2024.
More Zimmer Biomet Holdings, Inc. News

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Head office United States
CEO Ivan Tornos
Employees 18,000
Founded 1927
Website www.zimmerbiomet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today